Two-step islet autoantibody screening for risk assessment of type 1 diabetes in relatives

Diabetes Care

Volumn 21, Issue 9, 1998, Pages 1445-1450

  Pastore, Matteo R ^a   Bazzigaluppi, Elena ^a   Bonfanti, Riccardo ^a   Dozio, Nicoletta ^a   Sergi, Alessandro ^a   Balini, Annalisa ^a   Belloni, Cristina ^a   Meschi, Franco ^a   Bonifacio, Ezio ^a   Bosi, Emanuele ^a,b  

^a UNIVERSITY OF MILAN   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; PANCREAS ISLET CELL ANTIBODY;

ADULT; ANTIBODY DETECTION; ARTICLE; FAMILY; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; NORMAL HUMAN; PREDICTION; RELATIVE; RISK ASSESSMENT; SCREENING;

EID: 17144475242     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.21.9.1445     Document Type: Article

References (37)

1. Bach JF: Insulin-dependent diabetes mellitus as an autoimmune disease. Endocrine Rev 15:516-542, 1995
2. Bottazzo GF, Florin-Christensen A, Doniach D: Islet cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiency. Lancet ii:1279-1283, 1974
3. Bonifacio E, Genovese S, Braghi S, Bazzigaluppi E, Lampasona V, Bingley PJ, Rogge L, Pastore MR, Bognetti E, Bottazzo GF, Gale AEM, Bosi E: Islet autoantibody markers in insulin dependent diabetes: risk assessment strategies yielding high sensitivity Diobetologia 38:816-822, 1995
4. Hagopian WA, Sanjeevi CB, Kockum I, Landin-Olsson M, Karlsen AE, Sundkvist G, Dahlquist G, Palmer J, Lernmark A: Glutamate decarboxylase-, insulin-, and islet cell-antibodies and HLA typing to detect diabetes in a general population-based study of Swedish children. J Clin Invest 95:1505-1511, 1995
5. Bonifacio E, Bingley PJ, Dean BM, Shattock M, Dunger D, Gale EAM, Bottazzo GF: Quantification of islet cell antibodies and prediction of insulin-dependent diabetes. Lancet 335:147-149, 1990
6. Riley WJ, Maclaren NK, Krischer J, Spillar RP, Silverstein JH, Schatz DA, Schwartz S, Malone J, Shah S, Vadheim C, Rotter JI: A prospective study of the development of diabetes in relatives of patients with insulin-dependent diabetes. N Engl J Med 323: 1167-1172, 1990
7. Keller RJ, Eisenbarth GS, Jackson RA: Insulin prophylaxis in individuals at risk of type 1 diabetes. Lancet 341:927-928, 1993
8. Mandrup-Poulsen T, Reimers JI, Andersen HU, Pociot F, Karlsen AE, Bjerre U: Nicotinamide treatment in the prevention of insulin-dependent diabetes mellitus. Diabetes Metab Rev 9:295-309, 1993
9. Bonifacio E, Boitard C, Gleichmann H, Shattock MA, Molenaar JL, Bottazzo GF: Assessment of precision, concordance, specificity and sensitivity of islet cell antibody measurement in 41 assays. Diabetologia 33:731-736, 1990
10. Palmer JP, Asplin CM, Clemons P, Lyen K, Tatpati O, Raghu PK, Paquette TL: Insulin antibodies in insulin-dependent diabetics before insulin treatment. Science 222:1337-1339, 1983
11. Baekkeskov S, Aanstoot HJ, Christgau S, Reetz A, Solimena M, Cascalho M, Folli F, Richter-Olesen H, De Camilli P: Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 347:151-156, 1990
12. Rabin DU, Pleasic SM, Shapiro JA, YooWarren H, Oles J, Hicks JM, Goldstein DE, Rae PMM: Islet cell antigen 512 is a diabetes-specific autoantigen related to protein tyrosine phosphatases. J Immunol 152: 3183-3188, 1994
13. Lu J, Li Q, Xie H, Chen ZJ, Borovitskaya AE, Maclaren NK, Notkins AL, Lan MS: Identification of a second transmembrane protein tyrosine phosphatase IA-2beta, as an autoantigen in insulin-dependent diabetes mellitus: precursor of the 37-kDa tryptic fragment. Proc Natl Acad Sci U S A 93:2307-2311, 1996
14. Genovese S, Bonifacio E, McNally J, Wagner R, Dean BM, Bosi E, Gale EAM, Bottazzo GF: Distinct cytoplasmic islet cell antibodies with different risks for type I (insulin dependent) diabetes. Diabetologia 35:385-389, 1992
15. Marshall MO, Moyer PE, Petersen JS, Hejnaes KR, Genovese S, Dyrberg T, Bottazzo GF: Contribution of glutamate decarboxylase antibodies to the reactivity of cytoplasmic islet cell antibodies. J Autoimmimity 7:497-501, 1994
16. Bonifacio E, Lampasona V, Genovese S, Ferrari M, Bosi E: Identification of protein tyrosine phosphatase-like IA-2 (islet cell antigen 512) as the insulin-dependent diabetes-related 37/40K autoantigen and a target of islet-cell antibodies. J Immunol 155:5419-5426, 1995
17. Myers MA, Rabin DU, Rowley MJ: Pancreatic islet cell cytoplasmic antibody in diabetes is represented by antibodies to islet cell antigen 512 and glutamic acid decar- boxylase. Diabetes 44:1290-1295, 1995
18. Petersen JS, Hejnaes KR, Moody A, Karlsen AE, Marshall MO, Hoier-Madsen M, Boel E, Michelsen BK, Dyrberg T: Detection of GAD65 antibodies in diabetes and other autoimmune diseases using a simple radioligand assay. Diabetes 43:459-467, 1994
19. Verge CF, Stenger D, Bonifacio E, Colman PG, Bingley PJ, Eisenbarth GS, participating laboratories: Combined islet autoantibody workshop (Abstract). Diabetes 45 (Suppl. 2):81A, 1996
20. Lévy-Marchal C, Bridel MP, Sodoyez-Goffaux F, Koch M, Tichet J, Czemichow P, Sodoyez JC: Superiority of radiobinding assay over ELISA for detection of IAAs in newly diagnosed type 1 diabetic children. Diabetes Care 14:61-63, 1991
21. Moody AJ, Hejnaes KR, Marshall MO, Larsen FS, Boel E, Svendsen I, Mortensen E, Dyrberg T: Isolation by anion-exchange of immunologically and enzymatically active human islet glutamic acid decarboxylase 65 overexpressed in Sf9 insect cells. Diabetologa 38:14-23, 1995
22. Bingley PJ, Bonifacio E, Gale EAM: Can we really predict IDDM? Diabetes 42:213-220, 1993
23. + relatives. Diabetes 45:1720-1728, 1996
24. Verge CF, Gianani R, Kawasaki E, Yu L, Pietropaolo M, Jackson RA, Chase HP, Eisenbarth GS: Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies. Diabetes 45:926-933, 1996
25. Bingley PJ, Christie MR, Bonifacio E, Bonfanti R, Shattock M, Fonte MT, Bottazzo GF, Gale EAM: Combined analysis of autoantibodies improves prediction of IDDM in islet cell antibody-positive relatives. Diabetes 43: 1304-1310, 1994
26. Seissler J, Morgenthaler NG, Achenbach P, Lampeter EF, Glawe D, Payton M, Christie M, Scherbaum WA, the DENIS Study Group: Combined screening for autoantibodies to IA-2 and antibodies to glutamic acid decarboxylase in first degree relatives of patients with IDDM. Diabetologia 39:1351-1356, 1996
27. Gorus FK, Goubert P, Semakula C, Vandewalle CL, De Schepper J, Scheen A, Christie MR, Pipeleers DG, Belgian Diabetes Registry: IA-2 autoantibodies complement GAD65-autoantibodies in new-onset IDDM patients and help predict impending diabetes in their siblings. Diabetologia 40: 95-99, 1997
28. Williams AJK, Bingley PJ, Bonifacio E, Palmer JP, Gale EAM: A novel microassay for insulin autoantibodies. J Autoimmunity 10:473-478, 1997
29. Vardi P, Ziegler AG, Mathews JH, Dib S, Keller RJ, Ricker AT, Wolfsdorf JI, Herskowitz RD, Rabizadeh A, Eisenbarth GS, Soeldner JS: Concentration of insulin autoantibodies at onset of type 1 diabetes: inverse log-linear correlation with age. Diabetes Care 11:736-739, 1988
30. Lorenzen T, Pociot F, Hougaard P, Nerup J: Long-term risk of IDDM in first degree relatives of patients with IDDM. Diabetologia 37:321-327, 1994
31. Knip M, Vahasalo P, Karjalainen J, Lounamaa R, Akerblom HK, the Childhood Diabetes in Finland Study Group: Natural history of preclinical IDDM in high risk siblings. Diabetologia 37:388-393, 1994
32. Calori G, Callus G, Garancini P, Repetto F, Micossi P: Identification of the cohort of type 1 diabetes presenting in Lombardy in 1983-84: a validated assessment. Diabet Med 7:595-599, 1990
33. Green A, Gale EAM, Patterson CC, for the EURODIAB ACE Study Group: Incidence of childhood-onset insulin-dependent diabetes mellitus: the EURODIAB ACE Study Group. Lancet 339:905-909, 1992
34. Green A, the EURODIAB ACE Study Group: Geographic variation in the recurrence risk in close relatives of childhood onset IDDM patients (Abstract). Diabetologia 37(Suppl. 1):A6, 1994
35. Thivolet CH, Tappaz M, Durand A, Petersen J, Stefanutti A, Chatelain P, Vialettes B, Scherbaum WA, Orgiazzi J: Glutamic acid decarboxylase (GAD) autoantibodies are additional predictive markers of type 1 (insulin-dependent) diabetes mellitus in high risk individuals. Diabetologia 35:570-576, 1992
36. Roll U, Christie MR, Standl E, Ziegler AG: Associations of anti-GAD antibodies with islet cell antibodies and insulin autoantibodies in first-degree relatives of type I diabetic patients. Diabetes 43:154-160, 1994
37. Dittler J, Seidel D, Schenker M, Ziegler AG: GADIA2-combi determination as first-line screening for improved prediction of type 1 diabetes in relatives. Diabetes 47:592-598, 1998